Ertapenem/Zidebactam (Wockhardt)

N/A

Report date: 2025/07/25 10:36:06
QIDP

Base Information

Drug NameErtapenem/Zidebactam (Wockhardt)
Drug Alias NameWCK-6777
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes ZidebactamErtapenem Sodium
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt LtdNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A